Kanjinti Injection and Lithium Controlled-Release and Extended-Release Tablets
Determining the interaction of Kanjinti Injection and Lithium Controlled-Release and Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: trastuzumab
Brand name: Herceptin, Kanjinti, Ogivri
Synonyms: Kanjinti
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kanjinti Injection-Lithium ER
- Kanjinti Injection-Lithium Oral Solution
- Kanjinti Injection-Lithium Salts
- Kanjinti Injection-Lithium Syrup and Oral Solution
- Kanjinti Injection-Lithobid
- Kanjinti Injection-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-KANK-A
- Lithium Controlled-Release and Extended-Release Tablets-Kank-A Soft Brush
- Lithium Controlled-Release and Extended-Release Tablets-Kantrex
- Lithium Controlled-Release and Extended-Release Tablets-Kao-Paverin Caps
- Lithium Controlled-Release and Extended-Release Tablets-Kao-Tin Advanced Formula
- Lithium Controlled-Release and Extended-Release Tablets-Kaodene A-D